DK114556B - Fremgangsmåde til fremstilling af 1,4-benzodiazepin-2-on-4-oxider. - Google Patents

Fremgangsmåde til fremstilling af 1,4-benzodiazepin-2-on-4-oxider.

Info

Publication number
DK114556B
DK114556B DK29967AA DK29967A DK114556B DK 114556 B DK114556 B DK 114556B DK 29967A A DK29967A A DK 29967AA DK 29967 A DK29967 A DK 29967A DK 114556 B DK114556 B DK 114556B
Authority
DK
Denmark
Prior art keywords
benzodiazepin
oxides
preparation
Prior art date
Application number
DK29967AA
Other languages
Danish (da)
English (en)
Inventor
G Archer
L Sternbach
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK114556B publication Critical patent/DK114556B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/74Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/74Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • C07D239/76N-oxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK29967AA 1966-01-19 1967-01-18 Fremgangsmåde til fremstilling af 1,4-benzodiazepin-2-on-4-oxider. DK114556B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52155166A 1966-01-19 1966-01-19

Publications (1)

Publication Number Publication Date
DK114556B true DK114556B (da) 1969-07-14

Family

ID=24077176

Family Applications (4)

Application Number Title Priority Date Filing Date
DK29867AA DK120347B (da) 1966-01-19 1967-01-18 Fremgangsmåde til fremstilling af 1,4-benzodiazepin-4-oxider.
DK29967AA DK114556B (da) 1966-01-19 1967-01-18 Fremgangsmåde til fremstilling af 1,4-benzodiazepin-2-on-4-oxider.
DK537067AA DK120392B (da) 1966-01-19 1967-10-27 Analogifremgangsmåde til fremstilling af quinazolinderivater.
DK582367AA DK119656B (da) 1966-01-19 1967-11-21 Analogifremgangsmåde til fremstilling af kvaternære ammoniumsalte af 2'-benzoyl-2-aminoacetanilid-oximer eller syresalte deraf.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK29867AA DK120347B (da) 1966-01-19 1967-01-18 Fremgangsmåde til fremstilling af 1,4-benzodiazepin-4-oxider.

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK537067AA DK120392B (da) 1966-01-19 1967-10-27 Analogifremgangsmåde til fremstilling af quinazolinderivater.
DK582367AA DK119656B (da) 1966-01-19 1967-11-21 Analogifremgangsmåde til fremstilling af kvaternære ammoniumsalte af 2'-benzoyl-2-aminoacetanilid-oximer eller syresalte deraf.

Country Status (16)

Country Link
US (1) US3446806A (sv)
JP (1) JPS4938814B1 (sv)
BE (2) BE692378A (sv)
CH (3) CH560692A5 (sv)
DE (2) DE1695176A1 (sv)
DK (4) DK120347B (sv)
ES (2) ES335789A1 (sv)
FI (1) FI47576C (sv)
FR (2) FR1507878A (sv)
GB (2) GB1144516A (sv)
GR (2) GR33806B (sv)
IL (2) IL27189A (sv)
MY (2) MY6900384A (sv)
NL (3) NL6700786A (sv)
OA (1) OA02391A (sv)
SE (4) SE353717B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310429A (en) * 1978-06-19 1982-01-12 The B. F. Goodrich Company Stabilized polymers, novel stabilizers, and synthesis thereof
US4601839A (en) * 1978-06-19 1986-07-22 The B. F. Goodrich Company Stabilized polymers, novel stabilizers, and synthesis thereof
US4472435A (en) * 1980-07-31 1984-09-18 Hoffman-La Roche Inc. Benzophenone derivatives useful in treating heart failure
WO1995024394A1 (en) * 1994-03-08 1995-09-14 Takeda Chemical Industries, Ltd. Quinoline or quinazoline derivatives as anti-inflammatory agents, in particular for treating arthritis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3267110A (en) * 1960-06-03 1966-08-16 Smith Kline French Lab Trifluoromethyl substituted o-aminophenyl ketones
US3321467A (en) * 1963-11-27 1967-05-23 Hoffmann La Roche 3-halo-1, 4-benzodiazepin-2-ones

Also Published As

Publication number Publication date
ES335789A1 (es) 1967-12-16
FI47576B (sv) 1973-10-01
DK119656B (da) 1971-02-08
JPS4938814B1 (sv) 1974-10-21
US3446806A (en) 1969-05-27
NL6700785A (sv) 1967-07-20
IL27212A (en) 1971-04-28
GB1144516A (en) 1969-03-05
OA02391A (fr) 1970-05-05
SE353717B (sv) 1973-02-12
DK120392B (da) 1971-05-24
DE1695176A1 (de) 1970-04-16
SE321233B (sv) 1970-03-02
SE386168B (sv) 1976-08-02
FI47576C (sv) 1974-01-10
DK120347B (da) 1971-05-17
IL27189A (en) 1971-01-28
CH553193A (en) 1974-08-30
CH560692A5 (sv) 1975-04-15
MY6900384A (en) 1969-12-31
ES335788A1 (es) 1968-03-16
FR1508490A (fr) 1968-01-05
GR35752B (el) 1968-10-25
NL131198C (sv)
MY6900383A (en) 1969-12-31
CH461517A (de) 1968-08-31
GR33806B (el) 1968-02-06
DE1618486A1 (de) 1971-04-01
NL6700786A (sv) 1967-07-20
BE692378A (sv) 1967-07-10
SE335858B (sv) 1971-06-14
BE692558A (sv) 1967-07-13
GB1144515A (en) 1969-03-05
FR1507878A (fr) 1967-12-29

Similar Documents

Publication Publication Date Title
DK120546B (da) Fremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimidiner.
DK118877B (da) Analogifremgangsmåde til fremstilling af 3,1-benzoxazin-2-oner.
DK119005B (da) Fremgangsmåde til fremstilling af 3-alkoxy-13-alkylgona-1,3,5(10),8,14-penten-17-oner.
DK112523B (da) Fremgangsmåde til fremstilling af 2,3-pyridindiol.
DK116357B (da) Fremgangsmåde til fremstilling af 1,1,1,2,2-pentafluor-3-chlorpropan.
DK114556B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepin-2-on-4-oxider.
DK115184B (da) Fremgangsmåde til fremstilling af 6,7-benzomorphaner.
DK123169B (da) Fremgangsmåde til fremstilling af 2,5-dichlor-4-alkylmercaptophenoler.
DK114273B (da) Fremgangsmåde til fremstilling af α-methyl-α-amino-β-(3,4-disubstituerede-phenyl)-propionitriler.
DK115622B (da) Fremgangsmåde til fremstilling af 3-oxogona-4,9,11-triener.
DK120131B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener.
DK116594B (da) Fremgangsmåde til fremstilling af 4,1,5-benzoxadiazociner.
DK118406B (da) Fremgangsmåde til fremstilling af 3-alkynyloxy- og 3-alkenyloxy-4-sulfanilamido-1,2,5-thiadiazoler.
DK126936B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener.
DK114962B (da) Fremgangsmåde til fremstilling af α, α, α', α'-tetramethyl-xylylen-dicarbinoler.
DK112031B (da) Fremgangsmåde til fremstilling af 3,20-dioxo-17α-methyl-19-nor-pregna-4,9,11-trien.
DK114063B (da) Fremgangsmåde til fremstilling af 1-methyl-2-isopropyl-5-nitro-imidazol.
DK127418B (da) Fremgangsmåde til fremstilling af 13-alkyl-gona-1,3,5(10),6,8,14-hexaener.
DK117955B (da) Analogifremgangsmåde til fremstilling af N<4>-acrylerede 1-halogenbenzen-2,4-disulfonamider.
DK116368B (da) Fremgangsmåde til fremstilling af 2,3-dihydro-2,2,4-trimethyl-7-benzofuranol.
DK120845B (da) Fremgangsmåde til fremstilling af 3β-formoxy-15α-halogen-14β-hydroxy-5β-card-20(22)-enolider.
DK113917B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetrachlorcyclohexanon.
DK116659B (da) Fremgangsmåde til fremstilling af 9α-hydroxy-11β-nitro-1,3,5(10)-østratriener.
DK126688B (da) Fremgangsmåde til fremstilling af 13-alkyl-gona-1,3,5(10),7-tetraener.
DK119108B (da) Fremgangsmåde til fremstilling af C-D-trans-3-hydroxy-13-alkyl-17-oxogona-1,3,5(10),6,8-pentener.